Tsubamoto Hiroshi Department
Specialty Division
Obstetrics and Gynecology, Clinical Medicine Seminars
Position
■ Journal
1.
Original article
Phase II study of interval debulking surgery followed by intraperitoneal chemotherapy for advanced ovarian cancer: a Kansai Clinical Oncology Group study (KCOG9812). 2013/01
2.
Original article
Regional coordination for end-of-life care in our department 2013/01
3.
Case report
A large seminoma occurring 20 years after diagnosis of complete androgen insensitivity syndrome: A case report. 2013/03
4.
Original article
Phase II study of carboplatin and weekly irinotecan combination chemotherapy in recurrent ovarian cancer: a Kansai clinical oncology group study (KCOG0330). 2013/03
5.
Case report
Long-term disease-free survival after radical local excision of low-grade myofibroblastic sarcoma of the vulva. 2013/04
6.
Case report
Long-term remission after multiple bone metastases following cervical cancer: A case report. 2013/04
7.
Original article
Phase II trial on neoadjuvant intravenous and trans-uterine arterial chemotherapy for locally advanced bulky cervical adenocarcinoma. 2013/04
8.
Case report
Ovarian carcinoma in situ of presumable fallopian tube origin in a patient with Lynch syndrome: A case report. Gynecol Oncol Rep. 2013/05
9.
Case report
A case of primary metastatic glassy cell carcinoma of the uterine cervix that responded to combined docetaxel and carboplatin. 2013/07
10.
Original article
Prognostic factors for locally advanced cervical cancer treated with neoadjuvant intravenous and transuterine arterial chemotherapy followed by radical hysterectomy 2013/10
11.
Case report
Detection of unruptured ovarian pregnancy that was subsequently successfully treated by conservative laparoscopic surgery: A case report and review of the literature. 2013/12
12.
Original article
Development of an integrated support system for hereditary cancer and its impact on gynecologic services. 2013/12
13.
Original article
18F-Fluorodeoxyglucose uptake and clinicopathological features of recurrent or metastatic endometrial stromal sarcoma. 2014/02
14.
Case report
A case of endometrioid adenocarcinoma developing 8 years after conservative management for atypical polypoid adenomyoma. 2014/03
15.
Original article
Impact of combination chemotherapy with itraconazole on survival for patients with recurrent or persistent ovarian clear cell carcinoma. 2014/04
16.
Original article
Benefit of palliative chemotherapy and hospice enrollment in late-stage ovarian cancer patients. 2014/05
17.
Original article
Efficacy and safety of triple therapy with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy for gynecological cancer: KCOG-G1003 phase II trial. 2014/05
18.
Original article
Impact of combination chemotherapy with itraconazole on survival of patients with refractory ovarian cancer. 2014/05
19.
Original article
Feasibility and efficacy of intraperitoneal docetaxel administration as salvage chemotherapy for malignant gynaecological ascites. 2014/07
20.
Original article
Impact of itraconazole on the survival of heavily pre-treated patients with triple-negative breast cancer. 2014/07
21.
Original article
Expression of Chemokine Ligand 18 in Stage IA Low-grade Endometrial Cancer. 2014/10
22.
Case report
Complete remission achieved by oophorectomy for recurrent endometrial stromal sarcoma after laparoscopic morcellation. 2014/11
23.
Original article
Development of an integrated support system for hereditary cancer and its impact on gynecologic services. 2014/12
24.
Case report
Fatal case of multiple recurrences of endometrial stromal sarcoma after fertility-sparing management. 2015/01
25.
Original article
Combination Chemotherapy with Itraconazole for Treating Metastatic Pancreatic Cancer in the Second-line or Additional Setting. 2015/07
26.
Case report
Uterine metastasis of lung adenocinoma revealed by the same epidermal growth factor receptor mutation in both lung and endometrial biopsies 2015/08
27.
Original article
Impact of Itraconazole After First-line Chemotherapy on Survival of Patients with Metastatic Biliary Tract Cancer 2015/09
28.
Original article
Mitochondrial DNA copy number in cumulus cells is a strong
predictor of obtaining good-quality embryos after IVF 2015/12
29.
Case report
Bevacizumab helped resolve pericardial and pleural effusion that was associated with malignant ovarian clear cell carcinoma 2016/01
30.
Original article
Expression of Hedgehog Signals and Growth Inhibition
by Itraconazole in Endometrial Cancer 2016/01
31.
Original article
Gremlin 2 is Repressed in Invasive Endometrial Cancer
and Inhibits Cell Growth In Vitro 2016/01
32.
Case report
Pazopanib-mediated long-term disease stabilization after resection of a uterine leiomyosarcoma metastasis 2016/01
33.
Original article
Validation of the distress and impact thermometer and the changes of mood during the first 6 months of treatment in gynecological cancer patients: a Kansai Clinical Oncology Group (KCOG)-G1103 prospective study. 2016/11
34.
Original article
Itraconazole Inhibits AKT/mTOR Signaling and Proliferation in Endometrial Cancer Cells. 2017/02
35.
Introduction
Repurposing itraconazole as an anticancer agent (Review) 2017/04
36.
Original article
Current status of tertiary debulking surgery and prognosis after secondary debulking surgery for recurrent Müllerian epithelial cancer in Japan: a retrospective analysis of 164 patients (KCOG-G1402). 2017/07
37.
Original article
Itraconazole Modulates Hedgehog, WNT/β-catenin, as well as Akt Signalling, and Inhibits Proliferation of Cervical Cancer Cells 2017/07
38.
Case report
Pazopanib treatment of a platinum-resistant recurrence of a high-grade
Sertoli cell tumor and assessment of the treatment response by FDG-PET/CT:
A case report 2018/01
39.
Case report
Adolescent bladder endometriosis initially diagnosed as premenarchal disease: a case report and review of the literature 2018/03
40.
Case report
Bevacizumab with metronomic chemotherapy of low-dose oral
cyclophosphamide in recurrent cervical cancer: Four cases 2018/04
41.
Case report
Pazopanib treatment of a platinum-resistant recurrence of a high-grade Sertoli cell tumor and assessment of the treatment response by FDG-PET/CT: A case report. 2018/05
42.
Original article
Phase II study of adjuvant chemotherapy with paclitaxel and nedaplatin for uterine cervical cancer with lymph node metastasis. 2018/05
43.
Case report
Itraconazole treatment of primary malignant melanoma of the vagina evaluated using positron emission tomography and tissue cDNA microarray: a case report. 2018/06
44.
Original article
Effects of leuprorelin for the treatment of recurrent gynecological cancer by assessment including self-administered quality-of-life questionnaire 2019/01
45.
Original article
Multi-institutional phase II study of neoadjuvant irinotecan and nedaplatin followed by radical hysterectomy and the adjuvant chemotherapy for locally advanced, bulky uterine cervical cancer: A Kansai Clinical Oncology Group study (KCOG-G1201). 2019/03
46.
Original article
Challenges in Managing Patients with Hereditary Cancer at Gynecological Services 2019/05
47.
Original article
Phase I study on pegylated liposomal doxorubicin in combination with docetaxel for patients with platinum-resistant or partially platinum-sensitive epithelial ovarian Cancer: The Kansai Clinical Oncology Group Study 2019/10
48.
Original article
S-1, Oxaliplatin, Nab-paclitaxel and Itraconazole for Conversion Surgery for Advanced or Recurrent Gastric Cancer 2020/02
49.
Case report
Recurrent uterine serous carcinoma with a germline pathogenic BRCA2 variant treated using olaparib: A case report 2020/04
50.
Original article
Itraconazole increases resolvin E3 concentration and 12/15-lipoxygenase inhibitor attenuates its anticancer activity in cervical cancer cells 2021/09
51.
Original article
Itraconazole Inhibits Intracellular Cholesterol Trafficking and Decreases Phosphatidylserine Level in Cervical Cancer Cells 2021/11
52.
Case report
Successful Embolization of Collaterals from the Round Ligament Artery during Uterine Artery Embolization for Traumatic Uterine Leiomyoma Rupture: A Case Report 2021/11
53.
Original article
Clinical practice guideline for the treatment of malignant ascites : section summary in Clinical Practice Guideline for peritoneal dissemination(2021) 2022/01
54.
Original article
Metronomic chemotherapy using oral cyclophosphamide and bevacizumab for recurrent cervical cancer: A multi-institutional retrospective study 2022/05
55.
Original article
First-Line Gemcitabine, Nab-Paclitaxel, and Oxaliplatin Chemotherapy With Itraconazole in Patients With Metastatic Pancreatic Cancer: A Single Institution Experience 2022/11
56.
Case report
Extraskeletal Myxoid Chondrosarcoma of the Vulva: A Case Report 2023/01
57.
Original article
Itraconazole Repolarizes Tumor-associated Macrophages and Suppresses Cervical Cancer Cell Growth 2023/02
58.
Original article
Itraconazole Modulates Phospholipid Levels in Tumor-associated Macrophages 2023/03
59.
Original article
Comprehensive Genomic Profiling Detects Hereditary Cancers and Confers Survival Advantage in Patients With Gynaecological Cancers 2023/05
60.
Original article
Medroxyprogesterone as the Initial Systemic Treatment of Recurrent Endometrial Cancer: A Single Institutional Study 2023/06
61.
Original article
Weight‑Loss Interventions and Levonorgestrel Intrauterine System Implantation for Early‑Stage Endometrial Cancer and Atypical Endometrial Hyperplasia to Reduce Perioperative Risk of Severely Obese Patients 2023/07
62.
Original article
Phase II study of gemcitabine, cisplatin, and bevacizumab for first recurrent and refractory ovarian clear cell carcinoma Kansai Clinical Oncology Group-G1601 2023/08
63.
Case report
Fertility-sparing management of stage IIIC serous borderline ovarian tumor: A case report of a 20-year follow-up 2023/11
Interesting splice abnormality of MLH1 gene in a Japanese large scale family with Lynch syndrome (Oral presentation,General Lecture) 2013/08/31
2.
18F-fluorodeoxyglucose uptake and clinicopathological features of recurrent or metastatic endometrial stromal sarcome (ESS) (Poster presentation,General Lecture) 2013/10/19
3.
Benefit of palliative chemotherapy and hospice enrollment in late-stage ovarian cancer patients (Poster presentation,General Lecture) 2013/10/19
4.
Prognostic factors for cernical cancer treated with neoadjuvant trans-uterine arterial chemotherapy: A single-institution study (Poster presentation,General Lecture) 2013/10/19
5.
Combination chemotherapy with itraconazole for patients with recurrent or persistent ovarian clear cell carcinoma (Poster presentation,General Lecture) 2013/12/13
6.
Impact of itraconazole on yhe survival of heavily pretreated patients with triplenegative breast cancer. (Poster presentation,General Lecture) 2014/11/10
7.
Intraperitoneal and intrapleural administrations of traiamcinolone acetonide effective for control of malignant ascites and pleural effusion.(KCOG-G1102) (Poster presentation,General Lecture) 2014/11/10
8.
Translation research on endometrial cancer in Hyogo College of Medicine (Oral presentation,Symposium/Workshop/Panel Discussion) 2015/09/01
9.
Expression of Hedgehog signals and growth inhibition by itraconazole in endomertial (Poster presentation,General Lecture) 2016/04/16
10.
Gremlin2 is repressed in invasive endometrial cancer and inhibits cell growth in vitro (Poster presentation,General Lecture) 2016/04/16
11.
A three year experience of fertility preservation for AYA women (Poster presentation,General Lecture) 2016/05/21
12.
Presence and possible function of Gremlin2 in the human ovary (Poster presentation,General Lecture) 2016/05/21
13.
Repositioning itraconazole as an anticancer drug for endometrial cancer (Oral presentation,General Lecture) 2016/07/09
14.
Pseudomyxoma peritonei preoperatively diagnosed as a rupture of ovarian tumor; case report (Poster presentation,General Lecture) 2017/09/07
15.
Repurposing itraconazole for an anticancer agent: interim analysis of a window-of-opportunity study. (Poster presentation,General Lecture) 2017/11/06
16.
Fertility preservation by ovarian tissue cryopreservation for adolescent and young adult patients in our department (Oral presentation,General Lecture) 2018/05/11
17.
Repurposing itraconazole as an anticancer agent : rapid clinical response of metastatic vaginal melanoma (Poster presentation,General Lecture) 2018/05/11
18.
Vulvar apocrine adenocarcinoma responded to weekly paclitaxel and biweekly bevacizumab. A case report (Poster presentation,General Lecture) 2018/05/11
19.
Genomic profiling of primary peritoneal cancer with platinum sensitive recurrence. A two cases (Web announcement,General Lecture) 2020/04/24
20.
Metronomic chemotherapy using oral cyclophosphamide and bevacizumab (mCPA-BEV) for recurrent cervical cancer (Web announcement,General Lecture) 2020/04/25
21.
A long-team response to olaparib in a germline BRCA mutated patient with uterine serous carcinoma : A case report (Web announcement,General Lecture) 2020/04/26
22.
Bevacizumab with metronomic oral cyclophosphamide for patients with recurrent cervical cancer (Web announcement,General Lecture) 2020/09/10
23.
A phase II study of gemcitabine, cisplatin, and bevacizumab for first recurrent and refractory ovarian clear-cell carcinoma (KCOG-G1601 trial) (Web announcement,General Lecture) 2020/09/19
24.
Bevacizumab with metronomic oral cyclophosphamide for patients with recurrent cervical cancer (Web announcement,General Lecture) 2021/04/25
25.
Rapid response to itraconazole and transcript analysis of the cervical cancer tissue obtained by the sequential biopsy: A case report (Web announcement,General Lecture) 2021/04/25
26.
Resolvin E3 : The mechanism of anti-cancer effect of itraconazole in cervical cancer (Web announcement,General Lecture) 2021/04/25
27.
Case reports of obese endometrial cancer patients with levonorgestrel IUS to reduce the risk of laparoscopic surgery (Poster presentation,General Lecture) 2022/08/05
28.
Itraconazole inhibits intracellular cholesterol trafficking and decreasesphosphatidylserine level in cervical cancer cells (Poster presentation,General Lecture) 2022/08/05
29.
A case report of multilocus inherited neoplasia alleles syndrome (MINAS) with simultaneous Lynch syndrome and HBOC (Poster presentation,General Lecture) 2022/08/06
30.
Itraconazole repolarizes tumor-associated macrophages and suppresses cervical cancer growth (Poster presentation,General Lecture) 2022/10/22
31.
Extraskeletal Myxoid Chondrosarcoma (EMC) of the Vulva (Poster presentation,General Lecture) 2023/05/12
32.
Lynch Syndrome (LS) Caused by Rare Intronic Mutation in Mismatch Repair (MMR) Genes : Two Cases (Oral presentation,General Lecture) 2023/07/14